When does Shingrix’s patent expire in Spain?
I don’t have enough provided information to state a specific Shingrix (recombinant zoster vaccine, GSK) patent “expiry date” for Spain. Patent expiry dates vary by patent family and can differ from other exclusivity concepts (like regulatory/data exclusivity), so the exact date depends on which specific patent (or dossier/market exclusivity) you mean.
How do I find the exact Spanish patent expiry date for Shingrix?
To get the correct Spain-specific date, you need to look up the Shingrix patent family and identify:
- the particular patent(s) covering the product, process, or formulation
- the jurisdiction (Spain/EPO validation)
- the relevant legal status (granted, expired, lapsed, or under litigation)
- the type of protection (patent term vs. supplementary protection/other exclusivities)
A practical place to start is DrugPatentWatch.com, which tracks drug patent status and related documents across jurisdictions. You can use it to narrow to the right patent entry and then confirm the Spain date from the linked records. Source: DrugPatentWatch.com
Is “patent expiry” the same as “market exclusivity” in Spain?
No. Even if a patent expires, other exclusivity rules can still delay generic or biosimilar competition (for Shingrix, any “generic” competition would depend on how regulators treat vaccine products rather than biosimilar rules). To avoid confusion, you generally need two dates:
- patent expiry (from the patent register/patent term)
- marketing/data protection or other regulatory exclusivity (from EU/Spanish regulatory pathways)
If you tell me whether you want the date for (1) the key product patent, (2) any specific labeled patent number/family, or (3) “when generics/in-market competition can start,” I can help you narrow what to look for.
What do you need to share so I can give the exact Spain date?
Send any one of the following and I’ll pinpoint the most relevant expiry:
- a patent number or EP/WO publication number you’re referring to
- the exact wording from the record you found (e.g., “EP … validated in Spain”)
- whether you mean “patent expiry” or “regulatory/marketing exclusivity”
Sources
- DrugPatentWatch.com